Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses

Sponsor
Alcon Research (Industry)
Overall Status
Completed
CT.gov ID
NCT01839318
Collaborator
(none)
30
3
2

Study Details

Study Description

Brief Summary

The purpose of this study was to compare three CE-marked daily disposable contact lenses for tear film stability as measured by pre-lens non-invasive keratograph break up time (PL NIK-BUT). Secondarily, contact lens surface wettability was assessed.

Condition or Disease Intervention/Treatment Phase
  • Device: Nelfilcon A contact lenses
  • Device: Omafilcon A contact lenses
  • Device: Etafilcon A contact lenses
N/A

Detailed Description

Each participant wore 3 brands of contact lenses in a randomized, cross-over fashion, with a washout phase of at least 1 night between brands.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Official Title:
Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses Using Ring Mire Projection
Study Start Date :
Apr 1, 2013
Actual Primary Completion Date :
Jun 1, 2013
Actual Study Completion Date :
Jun 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: DAILIES AquaComfort Plus

Nelfilcon A contact lenses worn first, followed by etafilcon A and omafilcon A in randomized order. Each product worn for 1 day, 12 hours.

Device: Nelfilcon A contact lenses
Other Names:
  • DAILIES® AquaComfort Plus®
  • Active Comparator: 1-DAY ACUVUE MOIST

    Etafilcon A contact lenses worn first, followed by nelfilcon A and omafilcon A in randomized order. Each product worn for 1 day, 12 hours.

    Device: Etafilcon A contact lenses
    Other Names:
  • 1-DAY ACUVUE® MOIST®
  • Active Comparator: Proclear 1 day

    Omafilcon A contact lenses worn first, followed by etafilcon A and nelfilcon A in randomized order. Each product worn for 1 day, 12 hours.

    Device: Omafilcon A contact lenses
    Other Names:
  • Proclear® 1 day
  • Outcome Measures

    Primary Outcome Measures

    1. Pre-Lens Non-Invasive Keratograph Break Up Time (PL NIK-BUT) at 8 Hours [Hour 8]

      The pre-lens tear film is the layer of tears located on top of the contact lens (i.e., between the eye lid and the contact lens). The time required for a dry spot to appear on the corneal surface after blinking is referred to as the tear film break-up time. Circular images were projected onto the contact lens using an Oculus Keratograph 5 and the tear film reflection was observed. PL NIK-BUT was recorded at the first sign of distortion. A longer tear film break-up time indicates a more stable tear film. One eye (right eye) contributed to the mean.

    Secondary Outcome Measures

    1. Total Wettability Score [Hour 8]

      The investigator graded lens wettability by corneal region using a scale from 0 (fully wettable) to 3 (clearly visible ring distortions in more than 1/3 of ring reflection zone). The total wettability score per eye was calculated by averaging the grade of each of the 5 corneal regions (central, superior, nasal, inferior, and temporal). One eye (right eye) contributed to the mean.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 44 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Sign Informed Consent.

    • Adapted soft contact lens wearer.

    • Willing to wear contact lenses up to 12 hours and attend all study visits.

    • Vision correctable to 0.1 (logMAR) or better in each eye at distance with pre-study lenses at Visit 1.

    • Contact lens prescription within the power range specified in the protocol.

    • Other protocol-defined inclusion criteria may apply.

    Exclusion Criteria:
    • Any ocular infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear.

    • Any use of systemic or ocular medications that would contraindicate contact lens wear.

    • Any ocular finding observed during the Visit 1 examination that would contraindicate contact lens wear.

    • Monocular (only 1 eye with functional vision) or fit with only 1 lens.

    • History of herpetic keratitis, ocular surgery, or irregular cornea.

    • Known pregnancy.

    • Unstable tear film with a NIK-BUT value below 13 seconds in either eye without lenses.

    • Participation in any clinical study within 30 days of Visit 1.

    • Other protocol-defined exclusion criteria may apply.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Alcon Research

    Investigators

    • Study Director: Jessie Lemp, PhD, Alcon Research

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alcon Research
    ClinicalTrials.gov Identifier:
    NCT01839318
    Other Study ID Numbers:
    • A01336
    First Posted:
    Apr 24, 2013
    Last Update Posted:
    Jun 20, 2014
    Last Verified:
    May 1, 2014

    Study Results

    Participant Flow

    Recruitment Details Participants were recruited from 1 study center located in Germany.
    Pre-assignment Detail Of the 30 enrolled, 2 participants discontinued before product was dispensed. This reporting group includes all participants exposed to the study product (28). In this 3-treatment, 6-sequence crossover study, each participant received all 3 products in randomized order and used 1 product at a time for a duration of 12 hours.
    Arm/Group Title Sequence 1 Sequence 2 Sequence 3 Sequence 4 Sequence 5 Sequence 6
    Arm/Group Description Omafilcon A contact lenses worn first, followed by nelfilcon A contact lenses worn second, then etafilcon A contact lenses worn last. Each product worn for 1 day, 12 hours. Omafilcon A contact lenses worn first, followed by etafilcon A contact lenses worn second, then nelfilcon A contact lenses worn last. Each product worn for 1 day, 12 hours. Nelfilcon A contact lenses worn first, followed by etafilcon A contact lenses worn second, then omafilcon A contact lenses worn last. Each product worn for 1 day, 12 hours. Nelfilcon A contact lenses worn first, followed by omafilcon A contact lenses worn second, then etafilcon A contact lenses worn last. Each product worn for 1 day, 12 hours. Etafilcon A contact lenses worn first, followed by omafilcon A contact lenses worn second, then nelfilcon A contact lenses worn last. Each product worn for 1 day, 12 hours. Etafilcon A contact lenses worn first, followed by nelfilcon A contact lenses worn second, then omafilcon A contact lenses worn last. Each product worn for 1 day, 12 hours.
    Period Title: Period 1, First Day of Wear
    STARTED 4 4 5 6 7 2
    COMPLETED 4 4 5 6 7 2
    NOT COMPLETED 0 0 0 0 0 0
    Period Title: Period 1, First Day of Wear
    STARTED 4 4 5 6 7 2
    COMPLETED 4 4 5 6 7 2
    NOT COMPLETED 0 0 0 0 0 0
    Period Title: Period 1, First Day of Wear
    STARTED 4 4 5 6 7 2
    COMPLETED 4 4 5 6 7 2
    NOT COMPLETED 0 0 0 0 0 0

    Baseline Characteristics

    Arm/Group Title Overall
    Arm/Group Description Nelfilcon A contact lenses, etafilcon A contact lenses, and omafilcon A contact lenses worn in a cross-over assignment.
    Overall Participants 28
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    24.96
    (3.54)
    Sex: Female, Male (Count of Participants)
    Female
    22
    78.6%
    Male
    6
    21.4%

    Outcome Measures

    1. Primary Outcome
    Title Pre-Lens Non-Invasive Keratograph Break Up Time (PL NIK-BUT) at 8 Hours
    Description The pre-lens tear film is the layer of tears located on top of the contact lens (i.e., between the eye lid and the contact lens). The time required for a dry spot to appear on the corneal surface after blinking is referred to as the tear film break-up time. Circular images were projected onto the contact lens using an Oculus Keratograph 5 and the tear film reflection was observed. PL NIK-BUT was recorded at the first sign of distortion. A longer tear film break-up time indicates a more stable tear film. One eye (right eye) contributed to the mean.
    Time Frame Hour 8

    Outcome Measure Data

    Analysis Population Description
    This analysis population includes all participants exposed to the study product with reportable values.
    Arm/Group Title DAILIES AquaComfort Plus 1-DAY ACUVUE MOIST Proclear 1 Day
    Arm/Group Description Nelfilcon A contact lenses worn in a randomized order for 1 day, 12 hours Etafilcon A contact lenses worn in a randomized order for 1 day, 12 hours Omafilcon A contact lenses worn in a randomized order for 1 day, 12 hours
    Measure Participants 27 26 27
    Mean (Standard Deviation) [seconds]
    5.28
    (5.71)
    3.46
    (4.52)
    4.93
    (6.34)
    2. Secondary Outcome
    Title Total Wettability Score
    Description The investigator graded lens wettability by corneal region using a scale from 0 (fully wettable) to 3 (clearly visible ring distortions in more than 1/3 of ring reflection zone). The total wettability score per eye was calculated by averaging the grade of each of the 5 corneal regions (central, superior, nasal, inferior, and temporal). One eye (right eye) contributed to the mean.
    Time Frame Hour 8

    Outcome Measure Data

    Analysis Population Description
    This analysis population includes all participants exposed to the study product with reportable values.
    Arm/Group Title DAILIES AquaComfort Plus 1-DAY ACUVUE MOIST Proclear 1 Day
    Arm/Group Description Nelfilcon A contact lenses worn in a randomized order for 1 day, 12 hours Etafilcon A contact lenses worn in a randomized order for 1 day, 12 hours Omafilcon A contact lenses worn in a randomized order for 1 day, 12 hours
    Measure Participants 27 26 27
    5 seconds post blink
    0.74
    (0.93)
    0.83
    (0.87)
    0.84
    (0.96)
    10 seconds post blink
    1.25
    (1.15)
    1.20
    (1.14)
    1.42
    (1.2)
    15 seconds post blink
    1.58
    (1.2)
    1.54
    (1.21)
    1.66
    (1.19)
    20 seconds post blink
    1.69
    (1.21)
    1.78
    (1.22)
    1.89
    (1.18)
    25 seconds post blink
    1.79
    (1.18)
    1.94
    (1.19)
    2.03
    (1.17)

    Adverse Events

    Time Frame Adverse events (AEs) were collected for the duration of the study (2 months). This analysis group includes all enrolled participants.
    Adverse Event Reporting Description An AE is defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in subjects, users or other persons, whether or not related to the medical device.
    Arm/Group Title DAILIES AquaComfort Plus 1-DAY ACUVUE MOIST Proclear 1 Day
    Arm/Group Description Nelfilcon A contact lenses worn in a randomized order for 1 day, 12 hours Etafilcon A contact lenses worn in a randomized order for 1 day, 12 hours Omafilcon A contact lenses worn in a randomized order for 1 day, 12 hours
    All Cause Mortality
    DAILIES AquaComfort Plus 1-DAY ACUVUE MOIST Proclear 1 Day
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN) / (NaN)
    Serious Adverse Events
    DAILIES AquaComfort Plus 1-DAY ACUVUE MOIST Proclear 1 Day
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/30 (0%) 0/30 (0%) 0/30 (0%)
    Other (Not Including Serious) Adverse Events
    DAILIES AquaComfort Plus 1-DAY ACUVUE MOIST Proclear 1 Day
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/30 (0%) 0/30 (0%) 0/30 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    Sponsor reserves the right of prior review of any publication or presentation of information related to the study.

    Results Point of Contact

    Name/Title Jessie Lemp, GMA Brand Lead
    Organization Alcon Research, Ltd.
    Phone 1-888-451-3937
    Email alcon.medinfo@alcon.com
    Responsible Party:
    Alcon Research
    ClinicalTrials.gov Identifier:
    NCT01839318
    Other Study ID Numbers:
    • A01336
    First Posted:
    Apr 24, 2013
    Last Update Posted:
    Jun 20, 2014
    Last Verified:
    May 1, 2014